Health officials to provide Molnupiravir and Paxlovid to Covid-19 sufferers in Thailand Two anti-viral drugs might be added to the Covid-19 remedy plan in Thailand. The Department of Medical Services shared that the Molnupiravir and Paxlovid medicines have been approved for treating Covid-19 patients. Molnupiravir is intended to deal with high-risk groups like elders and sufferers with continual illnesses. Relevant departments will focus on the usage of Paxlovid. ติดตั้งโซล่าเซลล์Huawei -19 treatment, the anti-viral Favipiravir, shall be limited for patients with moderate and severe symptoms solely.

The director of the division, Somsak Akkasilp, shared that the authorities will talk about the distribution and use particulars later. There may also be a study on the effectiveness of utilizing Molnupiravir, Paxlovid, and Favipiravir to give you a plan to make use of the medicines fairly and effectively.
The Ministry of Public Health informed that the Covid-19 remedy plan in Thailand can be adjusted according to the situation. Recently, the authorities shared Home Isolation and Community Isolation can be the first therapy provided to sufferers with delicate symptoms.
A pulmonary disease professional at Vichaiyut Hospital advised Thai media that Molnupiravir could assist cut back the severity of the illness and demise rates by about 30%. He stated the drugs can be given to patients at excessive risk.
SOURCE: WorkpointTODAY | Thairath